Health Services

245. Deputy Pádraig O'Sullivan asked the Minister for Health the current capacity of the Regional Fertility Hub at the Lee Clinic in Cork given that referrals increased from 710 in 2023 to 1,144 in 2024 before reducing to 1,010 in 2025; whether the reduction in referrals in 2025 reflects a capacity constraint rather than a reduction in demand; and if she will make a statement on the matter. [40579…

257. Deputy Ken O'Flynn asked the Minister for Health the total annual expenditure under the treatment abroad scheme in each year since 2020; the number of approved patients in each year; and the average approved expenditure per patient annually. [40614/26]

258. Deputy Ken O'Flynn asked the Minister for Health whether expenditure and activity data reviewed during quarterly treatment abroad scheme oversight meetings with the Department of Health is recorded in a standardised reporting format; and if she will provide copies of the reporting templates used. [40615/26]

259. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme records activity data by clinical speciality, treatment category, age cohort or referral pathway; and if she will provide a breakdown of the categories currently recorded. [40616/26]

260. Deputy Ken O'Flynn asked the Minister for Health the dates on which the treatment abroad scheme was audited by the HSE Internal Audit function or the Comptroller and Auditor General since 2020; the scope of each audit; and whether any recommendations or governance concerns were identified. [40617/26]

261. Deputy Ken O'Flynn asked the Minister for Health whether any internal reports, dashboards, expenditure summaries or performance-monitoring documents relating to the treatment abroad scheme are routinely furnished to the Department of Health; and if she will provide details of the documents concerned. [40618/26]

262. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme maintains separate expenditure or activity reporting for referrals involving minors. [40619/26]

263. Deputy Ken O'Flynn asked the Minister for Health the number of treatment abroad scheme applications submitted, approved, refused and withdrawn in each HSE health region in each year since 2020. [40620/26]

264. Deputy Ken O'Flynn asked the Minister for Health whether any internal analysis has been conducted comparing treatment abroad scheme referral rates per capita across HSE health regions. [40621/26]

265. Deputy Ken O'Flynn asked the Minister for Health whether any equality impact assessment or access equity review has been conducted in relation to regional variation in treatment abroad scheme utilisation. [40622/26]

266. Deputy Ken O'Flynn asked the Minister for Health the dates and titles of all Internal Audit Office or Comptroller and Auditor General audits relating to the treatment abroad scheme since 2020. [40623/26]

267. Deputy Ken O'Flynn asked the Minister for Health whether any approval-rate benchmarking exists between specialties, consultants or regions under the treatment abroad scheme. [40624/26]

268. Deputy Ken O'Flynn asked the Minister for Health which officer or division holds responsibility for monitoring consistency of treatment abroad scheme decision-making nationally. [40625/26]

289. Deputy Michael Cahill asked the Minister for Health to examine issues raised in correspondence (details supplied); and if she will make a statement on the matter. [40674/26]

1065. Deputy Charles Ward asked the Minister for Children, Disability and Equality the number of respite hours provided to families in County Donegal in each of the years of 2024 and 2025; the planned level of capacity for 2026; and if she will make a statement on the matter. [40209/26]

1157. Deputy Ken O'Flynn asked the Minister for Health if her Department maintains a central register identifying all statutory, non-statutory, intermediary-funded, and externally governed bodies receiving funding from the Department or the HSE; and if not, whether such a register will be established. [38919/26]

1158. Deputy Ken O'Flynn asked the Minister for Health whether any formal criteria or classification methodology is used by the Department or the HSE to determine whether a publicly funded organisation is categorised as statutory, non-statutory, voluntary, intermediary-funded, or publicly controlled for governance purposes; and if so, to provide details. [38920/26]

1159. Deputy Ken O'Flynn asked the Minister for Health whether her Department or the HSE has conducted any mapping exercise since 2020 identifying which publicly funded health-related bodies are subject to the Code of Practice for the Governance of State Bodies, the Charities Governance Code, service-level agreements, or alternative governance frameworks; and if so, to provide details. [38921/26]

1160. Deputy Ken O'Flynn asked the Minister for Health whether any publicly funded health-sector bodies classified by the Central Statistics Office as public bodies are legally independent companies limited by guarantee; the number identified; and the aggregate level of State funding provided to such bodies in each year since 2020. [38922/26]

1161. Deputy Ken O'Flynn asked the Minister for Health whether the Department has conducted any governance risk assessment regarding publicly funded bodies that are legally independent of the State but depend primarily on Exchequer funding; and if so, to provide details. [38923/26]

1223. Deputy Ken O'Flynn asked the Minister for Health if the HSE has assessed the clinical impact of reimbursement delays for patients with progressive neurological conditions where irreversible deterioration may occur during the assessment process. [39068/26]

1224. Deputy Ken O'Flynn asked the Minister for Health if the HSE maintains any target timeframe for completion of reimbursement assessments relating to treatments for progressive neurodegenerative diseases. [39069/26]

1252. Deputy Ken O'Flynn asked the Minister for Health whether any audit, review, or expenditure-control process has examined referral concentration patterns, repeat provider usage, or high-cost treatment clustering under the treatment abroad scheme since 2020. [39145/26]

1288. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any assessment of the long-term financial impact of increasing reliance on the treatment abroad scheme for procedures not currently available in Ireland. [39190/26]

1290. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records clinical outcomes, complication rates or patient satisfaction data in respect of procedures funded under the treatment abroad scheme. [39192/26]